Resources
14 Results (showing 1 - 10)
Results sorted by posted date (oldest first)
Results sorted by posted date (oldest first)
Posted 12/3/2019 (updated 3/28/2024)
The National Council for Behavioral Health, through the National Center of Excellence for Integrated Health Solutions (CIHS) grant award from SAMHSA, is the home of the newest evidence-based resources, tools and support for organizations working to integrate primary and behavioral health care.
Posted 6/15/2020 (updated 3/28/2024)
The Opioid Use Disorder, Pregnant Women and Neonatal Abstinence Syndrome (NAS): Addressing the Challenges (Part II) webinar took place on June 9, 2020.
Posted 12/23/2020 (updated 4/4/2024)
This article presents an important look into stigma of families impacted by NAS and the ways in which healthcare providers must work to combat stigma’s harmful effects, and explores directions for future research of strategies for reducing stigma amongst this population to improve engagement in healthcare and positive heath-seeking behaviors. The authors reported that mothers of infants with NAS experience intensified stigma surrounding SUDs and the challenge of overcoming exclusion, shame, and judgement of their ability to parent. In examining nurses’ perceptions of perinatal women with SUD, the authors found that many struggled with negative attitudes and prejudices towards mothers of infants with NAS that interfered with their ability to provide nonjudgmental care. The authors urge nurses to implement substantial strategies for addressing stigma through tools such as the ACTS script.
Posted 2/17/2021 (updated 4/4/2024)
This packet presents you with the tools, materials and resources necessary to kick off grant activities quickly and efficiently.
Posted 3/25/2021 (updated 4/5/2024)
Considerations for Addressing Neonatal Abstinence Syndrome (NAS)
Dr. Lopata, JBS NAS Technical Expert Leads, and NAS RCORP grantees from the Western Regions will discuss resources, stigma, best practices, and challenges in addressing NAS.
Posted 5/26/2021 (updated 4/10/2024)
Posted 9/1/2021 (updated 4/3/2024)
Posted 6/7/2022 (updated 3/27/2024)
Cohort-Specific Sessions/Activities and Day 2 Wrap-Up
Posted 6/7/2022 (updated 3/27/2024)
Cohort-Specific Sessions/Activities and Day 2 Wrap-Up
Posted 12/21/2022 (updated 3/27/2024)
The Substance Abuse and Mental Health Services Administration released a notice of proposed rulemaking that would allow certified opioid treatment programs to begin prescribing the drug via audio-only or video-enabled telehealth. See additional information under Policy Updates below. The proposed changes come on top of recent findings by HHS of the positive impact of its revised Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder that removed two longstanding requirements for obtaining a waiver to treat up to 30 patients with buprenorphine: 1) the requirement for specific training, and 2) the need for otherwise eligible clinicians to certify their ability to provide or refer patients for counseling and other services. Rural primary care providers have obtained the DEA waiver at a lower rate than urban clinicians; decreased burden and greater flexibility in the guidelines, along with broader use of telehealth could help close that gap.